Sélidji Todagbé Agnandji

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

Emmanuel B. Bache, Sélidji Todagbé Agnandji, Bertrand Lell et al. · The Lancet · 2015 · 671 citations

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

Daniel E. Neafsey, Michal Juraska, Trevor Bedford et al. · New England Journal of Medicine · 2015 · 437 citations · Full text

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 404 citations · Full text

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Michael White, Robert Verity, Jamie T. Griffin et al. · The Lancet Infectious Diseases · 2015 · 344 citations · Full text

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy

Carlota Dobaño, Héctor Sanz, Hermann Sorgho et al. · Nature Communications · 2019 · 154 citations · Full text

Vaccination, Vaccine Development, Different Circumsporozoite Epitopes +13